DIS@PAW 2026: A Good Cure? Arbitrating Life Science Disputes – German and International Perspectives

Presentation

The life science industry is truly global just like arbitration. Is resolving disputes by arbitration in this space therefore a good cure? In our seminar we explore the dispute needs of the life science industry from different perspectives. Do the different players from big pharma to biotechnological start-up have the same needs and resort to the same methods? What are the typical disputes in an innovation-driven and highly regulated industry where investment costs are massive, cooperation across borders common, protection of intellectual property rights critical and blockbuster opportunities globally scaled. What are experiences with arbitrating life science disputes and what innovations are desired?

More Information will follow soon.